State Street’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
State Street's TNYA Position: Q3 2026 in Review
State Street increased its Tenaya Therapeutics (TNYA) stake by 7.3% in Q3 2026, buying an estimated $37.6K and bringing the position to 760,321 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #3681.
State Street first reported a position in TNYA in Q3 2021 and has held it in 21 quarters since. The position peaked at $5.07M in Q1 2024. 96 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.
- State Street held 760,321 shares of Tenaya Therapeutics worth $459K as of Q3 2026.
- State Street bought 51,600 Tenaya Therapeutics shares in Q3 2026, an estimated $37.6K.
- Tenaya Therapeutics made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3681 holding.
- State Street first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 21 quarters since.
- State Street's Tenaya Therapeutics position peaked at $5.07M in Q1 2024.
- 96 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.
Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.